Related Experiment Videos

Chlamydia pneumoniae and newly diagnosed asthma: a case-control study in 1 to 6-year-old children

Matti Korppi1, Mika Paldanius, Anne Hyvarinen

  • 1Department of Paediatrics, Kuopio University Hospital, Kuopio, Finland. matti.korppi@uku.fi

Respirology (Carlton, Vic.)
|June 9, 2004
PubMed

Insights

Antibodies to Chlamydia pneumoniae were common in young children. This study found no significant difference in IgG antibodies between children with new asthma and healthy controls.

Area of Science:

  • Pediatric Allergy and Immunology
  • Infectious Disease Epidemiology
  • Respiratory Medicine

Background:

  • Chlamydia pneumoniae infection is a potential environmental factor implicated in the development of asthma.
  • Understanding the role of microbial agents in pediatric asthma onset is crucial for public health.
  • Previous research has suggested a possible link between C. pneumoniae exposure and asthma development.

Purpose of the Study:

  • To investigate the association between Chlamydia pneumoniae antibodies and the incidence of new-onset asthma in young children.
  • To compare serological markers of C. pneumoniae infection in children diagnosed with asthma versus age- and sex-matched controls.

Main Methods:

  • A case-control study involving 122 children aged 1-6 years with newly diagnosed asthma and 244 matched controls.
  • Serum samples were analyzed using enzyme immunoassay (EIA) and microimmunofluorescence (MIF) for C. pneumoniae antibodies (IgG, IgA, IgM).
  • Data collection occurred between 1996 and 2000, with serological testing in 2000.

Main Results:

  • IgG antibodies to C. pneumoniae were prevalent in both asthma patients (36%) and controls (31%) when detected by EIA.
  • No significant differences in IgG antibody concentrations or positivity were observed between the asthma group and the control group.
  • IgA and IgM antibody levels were low in both groups, with no clear distinction between cases and controls.

Conclusions:

  • The presence of IgG antibodies to Chlamydia pneumoniae, as detected by EIA, is common in young children and does not appear to be a differentiating factor for newly diagnosed asthma in this cohort.
  • This case-control study suggests that C. pneumoniae infection may not be a significant risk factor for the onset of asthma in children aged 1-6 years.
  • Further research may be needed to explore other potential infectious or environmental triggers for pediatric asthma.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...